CD4 and glioblastoma: Mixed lymphocyte reactions with either CD4+ or CD8+ T cells were performed to determine the potential of cDCs in stimulating T cell proliferation.<h4>Results</h4>The cellular contact of cDC1-like cells with RCT-treated glioblastoma cells shifted their immune phenotype to a more activated one, whereas the activation of cDC2-like cells was limited.